Patel Chem Specialities Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹27(32.14%)
Premium (ELP)
Following its successful public offering, Patel Chem Specialities Limited's made its market debut on Aug 01, 2025 and is now actively traded on the BSEplatform. The IPO mobilized 70,00,000 Shares in total capital, including 70,00,000 Shares in primary equity infusion.
The offering was structured with a price band of ₹82 to ₹84 and minimum investment lots of 1600 shares. Investor participation during the subscription window from Jul 25, 2025 to Jul 29, 2025 demonstrated market confidence in the company's prospects.
The allotment process concluded on Jul 30, 2025, allocating shares to successful bidders. The listing represents the culmination of the IPO process, transitioning the company to publicly traded status with enhanced transparency and governance standards.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Patel Chem Specialities Limited, established in 2008, is involved in the manufacturing and export of pharmaceutical excipients and specialty chemicals. These chemicals are essential in various industries such as pharmaceuticals, food, cosmetics, and industrial applications. They serve important roles like binding, thickening, stabilizing, gelling, and helping tablets break down properly. The company operates from two manufacturing units located in Vatva, Ahmedabad, and Talod, Himmatnagar. These facilities follow strict quality standards and hold certifications like US-DMF and GMP. Covering an area of 7,000 square yards, the facility has a production capacity of over 7,200 metric tons per year. It includes sections for storage, production, research and development, quality control, packaging, and warehousing. Patel Chem has expanded its presence across East Asia, Europe, the Middle East, North America, and Southeast Asia by delivering high-quality products that meet global standards. The company’s main products include Rheollose (used for thickening and stabilizing), Disolwell (a tablet disintegrant), Swellcal (another disintegrant), and AmyloTab (used to help tablets dissolve). As of November 30, 2024, the company has 109 employees.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Wide Industry Coverage – Delivers a variety of products and services to meet the needs of different sectors.
- Strong Leadership Team – Guided by experienced professionals with solid knowledge of the industry.
- International Market Presence – Reaches customers globally, helping grow sales and reduce risk.
- Unstable Raw Material Supply – No long-term supplier deals may cause delays or price changes.
- Connected Party Dealings – Frequent related party transactions may affect financial clarity and governance.
- Limited Sourcing Regions – Relying on few states and one country adds risk during regional issues.
- Bhupesh Patel
- Anshu Patel
- Vini Patel
Patel Chem Specialities Limited
Link Intime India Private Limited